Author name: mary

“We wanted to create a new standard for how things could be done more objectively and accurately. That’s fundamental to our mission at HistoIndex. At the end of the day, you want a better way to diagnose patients so that they can be treated more optimally, and in doing so, they can live longer and have a better quality of life.”

Zicom Group and Singapore Government agency SPRING Singapore will jointly make their first investment of S$2 million (A$1.9 million) into growth phase medtech start-up Histoindex Pte Ltd.

“After a biopsy a patient waits in a hospital bed, but now, instead of waiting a couple days until doctors know how to treat this patient, we can deliver results while the patient is still in the hospital.”

IBM has named HistoIndex Pte Ltd the winner of SmartCamp KickStart ASEAN, a competition for startup companies. The competition is designed to identify outstanding early stage entrepreneurs who are developing business ventures that align with IBM Smarter Planet vision.

Dr Gideon Ho shares his experience on benefitting from the government’s Get-Up programme, and moving towards his goal with a scientist secondment from A*STAR.

BioSpectrum Asia speaks to Dr Gideon Ho, CEO of Histoindex, which aims to bring a revolutionary platform into the global tissue diagnostics market for the detection and quantification of fibrosis.

HistoIndex sets new standards in fibrosis diagnosis and is recognised as an industry-leading emerging company in 2012!